The Healthcare Acquired Infection Market is expected to be around US$ 31.90 Billion by 2028 at a CAGR of 6.1% in the given forecast period.
Developing number of immune-compromised patients, developing geriatric populace, ecological drivers, for example, growing bacterial load in hospitals, poor hospital infrastructure, crowding, growing incidence of chronic diseases requiring a prolonged stay in hospitals, poor infection control practices. Methicillin-resistant Staphylococcus aureus (MRSA) is the quickest developing nosocomial disease and has been the reason for a developing market share. The developing danger of antibiotic-resistant microorganisms combined with developing medicinal services offices and confirmations is the basic driver of the market.
The global Healthcare Acquired Infection Market is segregated on the basis of Method of Treatment as Radiation, Sterilization, and Chemical. Based on Pathogen Types the global Healthcare Acquired Infection Market is segmented in Fungal, Viral, and Bacterial. Based on Type of Infection the global Healthcare Acquired Infection Market is segmented in Gastrointestinal Infections, Respiratory Infections, Urinary Tract Infections, Blood Stream Infections, and Surgical Site Infections.
The global Healthcare Acquired Infection Market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Healthcare Acquired Infection Market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
3M Company, Belimed AG, Cantel Medical Corp., GlaxoSmithKline, Merck & Co., Pfizer, Inc., Bayer, Getinge AB, STERIS Corporation, Becton Dickinson And Company, and others are among the major players in the global Healthcare Acquired Infection Market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Healthcare Acquired Infection Market has been segmented as below.
Healthcare Acquired Infection Market, By Method of Treatment
Healthcare Acquired Infection Market, By Pathogen Types
Healthcare Acquired Infection Market, By Type of Infection
Healthcare Acquired Infection Market, By Region
Healthcare Acquired Infection Market, By Company
The report covers:
Report Scope:
The global Healthcare Acquired Infection Market report scope includes detailed study covering underlying factors influencing the industry trends.
The report covers analysis on regional and country level Market dynamics. The scope also covers competitive overview providing company Market shares along with company profiles for major revenue contributing companies.
The report scope includes detailed competitive outlook covering Market shares and profiles key participants in the global Healthcare Acquired Infection Market share. Major industry players with significant revenue share include 3M Company, Belimed AG, Cantel Medical Corp., GlaxoSmithKline, Merck & Co., Pfizer, Inc., Bayer, Getinge AB, STERIS Corporation, Becton Dickinson And Company, and others.
Reasons to Buy this Report:
Customization
Customized report as per the requirement can be offered with appropriate recommendations.
Below are our New Reports :-
Population Health Management Market
1. Introduction
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
2. Research Methodology
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach – Segmental Market Analysis
2.5.2 Top-Down Approach – Parent Market Analysis
3. Executive Summary
4. Market Overview
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter’s Five Force Analysis
5. Healthcare Acquired Infection Market, By Method Of Treatment
5.1 Introduction
5.2 Radiation
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Sterilization
5.3.1 Market Overview
5.3.2 Market Size and Forecast
5.4 Chemical
5.4.1 Market Overview
5.4.2 Market Size and Forecast
6. Healthcare Acquired Infection Market, By Pathogen Types
6.1 Introduction
6.2 Fungal
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Viral
6.3.1 Market Overview
6.3.2 Market Size and Forecast
6.4 Bacterial
6.4.1 Market Overview
6.4.2 Market Size and Forecast
7. Healthcare Acquired Infection Market, By Type Of Infection
7.1 Introduction
7.2 Gastrointestinal Infections
7.2.1 Market Overview
7.2.2 Market Size and Forecast
7.3 Respiratory Infections
7.3.1 Market Overview
7.3.2 Market Size and Forecast
7.4 Urinary Tract Infections
7.4.1 Market Overview
7.4.2 Market Size and Forecast
7.5 Blood Stream Infections
7.5.1 Market Overview
7.5.2 Market Size and Forecast
7.6 Surgical Site Infections
7.6.1 Market Overview
7.6.2 Market Size and Forecast
8. Healthcare Acquired Infection Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 North America Healthcare Acquired Infection, By Method Of Treatment
8.2.2 North America Healthcare Acquired Infection, By Pathogen Types
8.2.3 North America Healthcare Acquired Infection, By Type Of Infection
8.3 Europe
8.3.1 Europe Healthcare Acquired Infection, By Method Of Treatment
8.3.2 Europe Healthcare Acquired Infection, By Pathogen Types
8.3.3 Europe Healthcare Acquired Infection, By Type Of Infection
8.4 Asia-Pacific
8.4.1 Asia-Pacific Healthcare Acquired Infection, By Method Of Treatment
8.4.2 Asia-Pacific Healthcare Acquired Infection, By Pathogen Types
8.4.3 Asia-Pacific Healthcare Acquired Infection, By Type Of Infection
8.5 Rest of the World
8.5.1 Rest of the World Healthcare Acquired Infection, By Method Of Treatment
8.5.2 Rest of the World Healthcare Acquired Infection, By Pathogen Types
8.5.3 Rest of the World Healthcare Acquired Infection, By Type Of Infection
9. Competitive Insights
9.1 Key Insights
9.2 Company Market Share Analysis
9.3 Strategic Outlook
9.3.1 Mergers & Acquisitions
9.3.2 New Product Development
9.3.3 Portfolio/Production Capacity Expansions
9.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
9.3.5 Others
10. Company Profiles
10.1 3M Company
10.1.1 Company Overview
10.1.2 Product/Service Landscape
10.1.3 Financial Overview
10.1.4 Recent Developments
10.2 Belimed AG
10.2.1 Company Overview
10.2.2 Product/Service Landscape
10.2.3 Financial Overview
10.2.4 Recent Developments
10.3 Cantel Medical Corp.
10.3.1 Company Overview
10.3.2 Product/Service Landscape
10.3.3 Financial Overview
10.3.4 Recent Developments
10.4 GlaxoSmithKline
10.4.1 Company Overview
10.4.2 Product/Service Landscape
10.4.3 Financial Overview
10.4.4 Recent Developments
10.5 Merck & Co.
10.5.1 Company Overview
10.5.2 Product/Service Landscape
10.5.3 Financial Overview
10.5.4 Recent Developments
10.6 Pfizer, Inc.
10.6.1 Company Overview
10.6.2 Product/Service Landscape
10.6.3 Financial Overview
10.6.4 Recent Developments
10.7 Bayer
10.7.1 Company Overview
10.7.2 Product/Service Landscape
10.7.3 Financial Overview
10.7.4 Recent Developments
10.8 Getinge AB
10.8.1 Company Overview
10.8.2 Product/Service Landscape
10.8.3 Financial Overview
10.8.4 Recent Developments
10.9 STERIS Corporation
10.9.1 Company Overview
10.9.2 Product/Service Landscape
10.9.3 Financial Overview
10.9.4 Recent Developments
10.10 Becton Dickinson And Company
10.10.1 Company Overview
10.10.2 Product/Service Landscape
10.10.3 Financial Overview
10.10.4 Recent Developments
The Healthcare Acquired Infection Market has been segmented as below.
Healthcare Acquired Infection Market, By Method of Treatment
Healthcare Acquired Infection Market, By Pathogen Types
Healthcare Acquired Infection Market, By Type of Infection
Healthcare Acquired Infection Market, By Region
Healthcare Acquired Infection Market, By Company
SUBSCRIBE TO OUR NEWSLETTERS
